Relationship between PPARγ Pro12Ala gene polymorphism and type 2 diabetic nephropathy risk in Asian population: results from a meta-analysis

References

• Zhou TB, Drummen GP, Jiang ZP, et al. Association of peroxisome proliferator-activated receptors/retinoic acid receptors with renal diseases. J Recept Signal Transduct Res 2013. [Epub ahead of print]. doi: 10.3109/10799893.2013.838786
   Google Scholar
• Ma JJ, Zhang T, Fang N, et al. Establishment of a cell-based drug screening model for identifying agonists of human peroxisome proliferator-activated receptor gamma (PPARgamma). J Pharm Pharmacol 2012;64:719–26
   Google Scholar
• Zhou TB, Ou C, Luo CP, Xu HL. Protective effects of PPARgamma agonist in glomerulosclerosis rats induced by adriamycin. Ren Fail 2012,34:940–1
   Web of Science ®Google Scholar
• Okunuki Y, Usui Y, Nakagawa H, et al. Peroxisome proliferator-activated receptor-gamma agonist pioglitazone suppresses experimental autoimmune uveitis. Exp Eye Res 2013;116C:291–7
   Google Scholar
• Jesse CR, Bortolatto CF, Wilhelm EA, et al. The peroxisome proliferator-activated receptor-gamma agonist pioglitazone protects against cisplatin-induced renal damage in mice. J Appl Toxicol 2012. [Epub ahead of print]. doi: 10.1002/jat.2818
   Google Scholar
• Ramirez A, Ballard EN, Roman J. TGFbeta1 controls PPARgamma expression, transcriptional potential, and activity, in part, through Smad3 signaling in murine lung fibroblasts. PPAR Res 2012;2012:375876
   Google Scholar
• Eid S, Abou-Kheir W, Sabra R, et al. Involvement of renal cytochromes P450 and arachidonic acid metabolites in diabetic nephropathy. J Biol Regul Homeost Agents 2013;27:693–703
   Google Scholar
• Mooyaart AL. Genetic associations in diabetic nephropathy. Clin Exp Nephrol 2013. [Epub ahead of print]. doi: 10.1007/s10157-013-0874-9
   Google Scholar
• Khajehdehi P, Pakfetrat M, Javidnia K, et al. Oral supplementation of turmeric attenuates proteinuria, transforming growth factor-beta and interleukin-8 levels in patients with overt type 2 diabetic nephropathy: a randomized, double-blind and placebo-controlled study. Scand J Urol Nephrol 2011;45:365–70
   PubMed Web of Science ®Google Scholar
• Zhou TB, Yin SS. Association of matrix metalloproteinase-9 level with the risk of renal involvement for Henoch-Schonlein purpura in children. Ren Fail 2013;35:425–9
   PubMed Web of Science ®Google Scholar
• Zhou TB, Yin SS, Liang R. A meta-analysis of the association between angiotensin-converting enzyme insertion/deletion gene polymorphism and end-stage renal disease risk in IgA nephropathy patients. J Renin Angiotensin Aldosterone Syst 2013;14:235–41
   PubMed Web of Science ®Google Scholar
• Cheng HY, You HY, Zhou TB. Relationship between GSTM1/GSTT1 null genotypes and renal cell carcinoma risk: a meta-analysis. Ren Fail 2012;34:1052–7
   PubMed Web of Science ®Google Scholar
• Zhou TB, Qin YH, Xu HL. Association of apoE gene expression and its gene polymorphism with nephrotic syndrome susceptibility: a meta-analysis of experimental and human studies. Mol Biol Rep 2012;39:9347–54
   PubMed Web of Science ®Google Scholar
• Zhou TB, Yin SS. Association of endothelial nitric oxide synthase Glu298Asp gene polymorphism with the risk of end-stage renal disease. Ren Fail 2013;35:573–8
   PubMed Web of Science ®Google Scholar
• Zhou TB, Yin SS, Jiang ZP. Association of angiotensin II type-1 receptor A1166C gene polymorphism with the susceptibility of end-stage renal disease. J Recept Signal Transduct Res 2013;33:325–31
   PubMed Web of Science ®Google Scholar
• Begg CB, Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics 1994;50:1088–101
   PubMed Web of Science ®Google Scholar
• Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997;315:629–34
   PubMed Web of Science ®Google Scholar
• Erdogan M, Karadeniz M, Eroglu Z, et al. The relationship of the peroxisome proliferator-activated receptor-gamma 2 exon 2 and exon 6 gene polymorphism in Turkish type 2 diabetic patients with and without nephropathy. Diabetes Res Clin Pract 2007;78:355–9
   Google Scholar
• Liu L, Zheng T, Wang F, et al. Pro12Ala polymorphism in the PPARG gene contributes to the development of diabetic nephropathy in Chinese type 2 diabetic patients. Diabetes Care 2010;33:144–9
   PubMed Web of Science ®Google Scholar
• Maeda A, Gohda T, Funabiki K, et al. Peroxisome proliferator-activated receptor gamma gene polymorphism is associated with serum triglyceride levels and body mass index in Japanese type 2 diabetic patients. J Clin Lab Anal 2004;18:317–21
   Google Scholar
• Mori H, Ikegami H, Kawaguchi Y, et al. The Pro12 –>Ala substitution in PPAR-gamma is associated with resistance to development of diabetes in the general population: possible involvement in impairment of insulin secretion in individuals with type 2 diabetes. Diabetes 2001;50:891–4
   Web of Science ®Google Scholar
• Wu LS, Hsieh CH, Pei D, et al. Association and interaction analyses of genetic variants in ADIPOQ, ENPP1, GHSR, PPARgamma and TCF7L2 genes for diabetic nephropathy in a Taiwanese population with type 2 diabetes. Nephrol Dial Transplant 2009;24:3360–6
   PubMedGoogle Scholar
• Zhang H, Zhu S, Chen J, et al. Peroxisome proliferator-activated receptor gamma polymorphism Pro12Ala is associated with nephropathy in type 2 diabetes: evidence from meta-analysis of 18 studies. Diabetes Care 2012;35:1388–93
   Google Scholar
• Wei F, Wang J, Wang C, et al. The relationship between the pro12Ala polymorphism in PPAR-γ2 gene and diabetic nephropathy in Baotou. Chinese J Diabetes 2008;16:679–80
   Google Scholar
• Zhu W, Ji Y, Bu L, Yang Q. The correlativity study of peroxisome proliferator activated receptor γ2 gene polymorphism with susceptibility of diabetic nephropathy in type 2 diabetes mellitus. J Radioimmunol 2011;24:296–8
   Google Scholar
• Li L, Liu L, Zheng T, et al. Peroxisome proliferator activated receptor γ2 gene P12A polymorphism and type 2 diabetic nephropathy in Han population in Shanghai. J Shanghai Jiaotong Univ 2008;28:376–9
   Google Scholar
• Wu S. Study on the relationship of polymorphism of PPAR-γ2 and type 2 diabetes and diabetic nephropathy [dissertation]. Tianjin: Tianjin Medical University; 2004
   Google Scholar
• Wang L, Teng Z, Cai S, et al. The association between the PPARgamma2 Pro12Ala polymorphism and nephropathy susceptibility in type 2 diabetes: a meta-analysis based on 9,176 subjects. Diagn Pathol 2013;8:118
   PubMed Web of Science ®Google Scholar
• De Cosmo S, Prudente S, Lamacchia O, et al. PPARgamma2 P12A polymorphism and albuminuria in patients with type 2 diabetes: a meta-analysis of case-control studies. Nephrol Dial Transplant 2011;26:4011–6
   Google Scholar